NASDAQ · Medical - Devices

LivaNova PLC (LIVN) Stock

$76.39 +0.63% NASDAQ: LIVN Healthcare

Valuation

MetricValue
Price$76.39
Market Cap$4.20B
P/E Ratio22.17
P/B Ratio3.17
P/S Ratio2.86
EPS (TTM)$1.96
52-Week High$85.76
52-Week Low$48.82
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE15.41%
ROA7.14%
ROCE10.25%
Gross Margin67.86%
Operating Margin14.39%
Net Margin12.82%
Debt/Equity0.27
Current Ratio1.33

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0B$1.0B$1.2B$1.3B$1.4B
Operating Profit$-1.0M$-77.0M$-68.0M$129.0M$199.0M
Net Profit$-136.0M$-86.0M$18.0M$63.0M$-242.0M
EPS$-2.68$-1.61$0.32$1.16$-4.45
Op Margin-0.1%-7.5%-5.9%10.3%14.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.2B$2.3B$2.4B$2.5B$2.6B
Total Liabilities$906.0M$1.1B$1.2B$1.2B$1.4B
Cash$208.0M$214.0M$267.0M$429.0M$636.0M
Borrowings$287.0M$580.0M$640.0M$677.0M$473.0M

Latest News

LIVN: Lowering target price to $83.00 Argus Research · Jul 15, 2026 LivaNova PLC (LIVN) Hit a 52 Week High, Can the Run Continue? Zacks · Jul 7, 2026 LivaNova to Announce Second-Quarter 2026 Results Business Wire · Jun 24, 2026 LivaNova Reports Improved OSA Outcomes With PolySync Programming Zacks · Jun 17, 2026 LivaNova's PolySync Algorithm Supports Improvement in Sleep Apnea Treatment Response Rate MT Newswires · Jun 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$103.0M$70.0M$75.0M$183.0M$254.0M
Investing Cash Flow$11.0M$-65.0M$-75.0M$-95.0M$-154.0M
Financing Cash Flow$-3.0M$-4.0M$-5.0M$-69.0M$-5.0M
Net Cash Flow$-45.0M$308.0M$62.0M$146.0M$-88.0M
Free Cash Flow$77.0M$43.0M$40.0M$136.0M$173.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.08
EV / EBITDA22.34
FCF Yield3.53%
Quick Ratio1.21
Interest Coverage4.30
Return 1Y44.85%
Return 3Y44.02%
Return 5Y-4.22%

Ownership

Insiders Held0.42%
Institutions Held112.89%
Institutions Float Held113.37%
Institutional HolderSharesReport Date
Blackrock Inc.7,138,9082026-03-31
Primecap Management Company4,207,0522026-03-31
FMR, LLC2,666,6742026-03-31
AQR Capital Management, LLC2,494,3722026-03-31
Millennium Management Llc2,438,6712026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BSXBoston Scientific Corporation $42.73 +1.64% 17.71 $63.51B 0.00%
CVRXCVRx, Inc. $1.58 -5.95% -0.78 $41.93M 0.00%
EWEdwards Lifesciences Corporation $85.21 +1.15% 49.59 $49.06B 0.00%
HAEHaemonetics Corporation $118.69 -0.65% 50.65 $5.39B 0.00%
INSPInspire Medical Systems, Inc. $68.89 +3.30% 15.01 $1.99B 0.00%

About LivaNova PLC

LivaNova PLC (LIVN) stock trades at $76.39 with a market capitalization of $4.20B. The stock is valued at a price-to-earnings (P/E) ratio of 22.17, price-to-book of 3.17, price-to-sales of 2.86. Over the past 52 weeks the stock has ranged between $48.82 and $85.76, and currently trades 10.9% below its 52-week high.

On profitability, LivaNova PLC generates a return on equity (ROE) of 15.41%, above the typical market average, return on capital employed of 10.25%, an operating margin of 14.39%, a net profit margin of 12.82%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides